Researchers at Michigan State University and Harvard Medical School have joined forces to develop a vaccine that will fight antibiotic-resistant infections.
Due to the overuse of antibiotics, pathogens are rapidly developing resistance to treatments. Antibiotic-resistant infections are estimated to have killed more than a million people worldwide in 2019, according to the World Health Organization, and there are concerns that within a few years most drugs will not be effective.
In a new study published in the journal Nature Communications, researchers, led by Xufei Huang, a professor at the Michigan State University Research Foundation, describe creating a vaccine candidate for antibiotic-resistant bacteria.
Researchers announced several breakthroughs that will help develop the carbohydrate-based vaccine and provide protection against infections caused by Staphylococcus aureus and MRSA, or methicillin-resistant Staphylococcus aureus.
The preclinical formulation of the vaccine developed by the team offered, the publication states, high levels of immunity against lethal levels of staph and MRSA in animal tests.
For this research, Xufei Huang received the 2024 Michigan State University Technology Transfer Achievement Award.
See also:
Kasselakis: “I talked about investing in Health 5% of GDP more than the current rate” – “Independent partners Georgiadis and New Left”
What does Adonis Georgiadis respond to Kallianos’ viral video about his father
Vicky Flessa covers Mitsotakis: We are to blame for the crime of Tempi! (Video)
#Research #Scientists #develop #vaccine #antibioticresistant #infections
